Skip to content
healthcare.dev
Get a free key

Rivastigmine Transdermal System

NDC 51991-897, Rivastigmine, patch, extended release, from Breckenridge Pharmaceutical, Inc..

Product NDC
51991-897
Status
Listed
Labeler
Breckenridge Pharmaceutical, Inc.
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209063
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51991-897 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE4.6 mg/24h

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
51991-897-305199108973030 POUCH in 1 CARTON (51991-897-30) / 1 PATCH in 1 POUCH (51991-897-99) / 24 h in 1 PATCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b201fe68-b5e5-4a6f-8cf1-069543f03e76

  • NADAC price for package 51991089730

    GET /v1/drugs/nadac/51991089730

Use it

Look up 51991-897 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51991-897 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51991-897. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.